Status:

COMPLETED

The Effects of Nutritional on Disease Activity and Functional Status in RA

Lead Sponsor:

Balikesir University

Conditions:

Rheumatoid Arthritis

Eligibility:

All Genders

18-75 years

Brief Summary

Rheumatoid arthritis (RA) is a chronic, autoimmune, systemic, inflammatory disease. RA is a chronic inflammatory disease in which many patients cannot achieve remission despite current pharmacologica...

Detailed Description

Rheumatoid arthritis (RA) is a chronic, autoimmune, systemic, inflammatory disease affecting 0.5-1.0% of the population. RA is a chronic inflammatory disease in which many patients cannot achieve remi...

Eligibility Criteria

Inclusion

  • Between the ages of 18-75,
  • Diagnosed with RA according to ACR 2010 diagnostic criteria,
  • RA disease duration at least ≥2 years

Exclusion

  • Pregnant
  • During the lactation period,
  • Malignancy
  • Using more than 10 mg of prednisolone per day,
  • The period after the diagnosis of Ra is ≤2 years,
  • Changes in medical treatment, DMARD and/or biological agent use in the last 8 weeks,
  • Patients who cannot understand the information in the questionnaires

Key Trial Info

Start Date :

December 20 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 31 2022

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT05227885

Start Date

December 20 2021

End Date

May 31 2022

Last Update

February 8 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Balikesir University

Balıkesir, Turkey (Türkiye), 10145